BOD Australia at near two-week high on record Q2 sales

Bod Science

18/01/2021 01:22

** Shares of BOD Australia Ltd  BDA.AX  rise as much as 8.5%
to A$0.51, their highest since Jan 7 
    ** The medicinal marijuana co says it generated record total
attributable sales of A$3.33 mln ($2.56 million) in Q2, up 144%
from last year  urn:newsml:reuters.com:*:nASN000Q3S 
    ** Sales in the quarter were lifted by purchase orders from
exclusive global partners Health and Happiness Group  1112.HK 
for the launch of CBD and hemp products into key markets
    ** Co pointed that increased prescription volumes of BOD's
medicinal cannabis product MediCabilis™ also underpinned sales
growth
    ** Sales growth expected to continue during current period
and beyond, co adds
    ** BOD Australia marks biggest intraday percentage gain in
about two weeks
    ** Stock down 4.1% this year, as of last close
    
   ($1 = 1.3001 Australian dollars)

 (Reporting by Ananya Pande in Bengaluru)
 ((ananya.pande@thomsonreuters.com))